Bernard Mazieres

Summary

Country: France

Publications

  1. ncbi Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study
    B Mazieres
    Service de Rhumatologie, CHU Rangueil, Toulouse, France
    J Rheumatol 28:173-81. 2001
  2. ncbi Adherence to, and results of, physical therapy programs in patients with hip or knee osteoarthritis. Development of French clinical practice guidelines
    Bernard Mazieres
    Service de Rhumatologie, CHU Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse Cedex 9, France
    Joint Bone Spine 75:589-96. 2008
  3. ncbi Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: the MESSAGE study
    Bernard Mazieres
    Rheumatology Department, Rangueil Teaching Hospital, Toulouse, France
    Joint Bone Spine 74:453-60. 2007
  4. ncbi Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study
    Bernard Mazieres
    Department of Rheumatology, Rangueil University Hospital1, avenue Jean Poulhes, 31059 Toulouse Cedex 9, France
    Ann Rheum Dis 66:639-45. 2007
  5. ncbi Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort
    B Mazieres
    Department of Rheumatology CHU Rangueil 1, avenue Jean Poulhes, Toulouse 31059, France
    Ann Rheum Dis 65:354-9. 2006
  6. ncbi Topical ketoprofen patch
    Bernard Mazieres
    Service de Rhumatologie, CHU Rangueil, Toulouse, France
    Drugs R D 6:337-44. 2005
  7. ncbi Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study
    Bernard Mazieres
    Department of Rheumatology, Rangueil University Hospital, Toulouse, France
    J Rheumatol 32:1563-70. 2005
  8. ncbi Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study
    Bernard Mazieres
    Department of Rheumatology, Rangueil University Hospital, 1, avenue Jean Poulhes, 31059 Toulouse Cedex 9, France
    Am J Sports Med 33:515-23. 2005
  9. ncbi Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries
    B Mazieres
    Department of Rheumatology, University Hospital of Rangueil, 1 avenue Jean Poulhes, 31059 Toulouse Cedex 9, France
    Ann Rheum Dis 64:1158-64. 2005
  10. ncbi EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials
    B Mazieres
    Université Paul Sabatier et service de rhumatologie, CHU Rangueil, Toulouse, France
    Joint Bone Spine 68:231-40. 2001

Detail Information

Publications20

  1. ncbi Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study
    B Mazieres
    Service de Rhumatologie, CHU Rangueil, Toulouse, France
    J Rheumatol 28:173-81. 2001
    ....
  2. ncbi Adherence to, and results of, physical therapy programs in patients with hip or knee osteoarthritis. Development of French clinical practice guidelines
    Bernard Mazieres
    Service de Rhumatologie, CHU Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse Cedex 9, France
    Joint Bone Spine 75:589-96. 2008
    ..To develop recommendations regarding adherence to physical therapy programs by patients with hip or knee osteoarthritis...
  3. ncbi Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: the MESSAGE study
    Bernard Mazieres
    Rheumatology Department, Rangueil Teaching Hospital, Toulouse, France
    Joint Bone Spine 74:453-60. 2007
    ..Our secondary objective was to evaluate treatment benefits in terms of pain, function, and quality of life...
  4. ncbi Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study
    Bernard Mazieres
    Department of Rheumatology, Rangueil University Hospital1, avenue Jean Poulhes, 31059 Toulouse Cedex 9, France
    Ann Rheum Dis 66:639-45. 2007
    ..To evaluate the efficacy and tolerability of chondroitin sulphate (chondroitin sulphate) in knee osteoarthritis...
  5. ncbi Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort
    B Mazieres
    Department of Rheumatology CHU Rangueil 1, avenue Jean Poulhes, Toulouse 31059, France
    Ann Rheum Dis 65:354-9. 2006
    ..To determine whether systemic markers of bone, cartilage, and synovium can predict structural progression of osteoarthritis (OA)...
  6. ncbi Topical ketoprofen patch
    Bernard Mazieres
    Service de Rhumatologie, CHU Rangueil, Toulouse, France
    Drugs R D 6:337-44. 2005
    ..Thus, the topical ketoprofen patch appears to be a simple, effective and safe therapeutic option for the treatment of local painful inflammation...
  7. ncbi Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study
    Bernard Mazieres
    Department of Rheumatology, Rangueil University Hospital, Toulouse, France
    J Rheumatol 32:1563-70. 2005
    ..To evaluate the efficacy and tolerability of ketoprofen patch in the treatment of tendinitis...
  8. ncbi Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study
    Bernard Mazieres
    Department of Rheumatology, Rangueil University Hospital, 1, avenue Jean Poulhes, 31059 Toulouse Cedex 9, France
    Am J Sports Med 33:515-23. 2005
    ....
  9. ncbi Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries
    B Mazieres
    Department of Rheumatology, University Hospital of Rangueil, 1 avenue Jean Poulhes, 31059 Toulouse Cedex 9, France
    Ann Rheum Dis 64:1158-64. 2005
    ..To evaluate the level of acceptability of the EULAR recommendations for the management of knee osteoarthritis (KOA) in practice...
  10. ncbi EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials
    B Mazieres
    Université Paul Sabatier et service de rhumatologie, CHU Rangueil, Toulouse, France
    Joint Bone Spine 68:231-40. 2001
    ..A task force for the EULAR standing committee for clinical trials determined the methodological and logistical approach required for the development of evidence-based guidelines for treatment of knee osteoarthirits (OA)...
  11. ncbi Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study
    Arnaud Constantin
    Centre Hospitalier Universitaire Rangueil, INSERM U558, and INSERM U395, Toulouse, France
    Arthritis Rheum 46:1754-62. 2002
    ....
  12. ncbi Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis
    Arnaud Constantin
    Centre Hospitalier Universitaire Rangueil, INSERM U558, and INSERM U563, Toulouse, France
    Arthritis Rheum 50:742-7. 2004
    ..The present study was undertaken to test the hypothesis that there is an association between this polymorphism and the severity of RA...
  13. ncbi Can ischemic hip disease cause rapidly destructive hip osteoarthritis? A case report
    Michel Laroche
    Rheumatology Department, CHU Rangueil, Toulouse, France
    Joint Bone Spine 69:76-80. 2002
    ..This case corroborates the hypotheses put forward by Lequesne that some cases of rapidly destructive hip osteoarthritis may be ascribable to ischemia...
  14. ncbi Chondroitin sulfate in the management of hip and knee osteoarthritis: an overview
    Géraldine Bana
    Paul Sabatier University, Faculty of Pharmacy, Toulouse, France
    Adv Pharmacol 53:507-22. 2006
  15. ncbi Systemic vasculitis revealing a benign tumor: a paraneoplastic syndrome?
    Marie Anne Plaut
    Rheumatology Department, Rangueil Teaching Hospital, 1, avenue Jean Poulhe, 31059 Toulouse, France
    Joint Bone Spine 73:462-4. 2006
    ..The symptoms resolved fully after tumor excision, supporting a diagnosis of paraneoplastic syndrome...
  16. ncbi Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation
    Soumaya El Mahou
    Hopital de Rangueil, 1, 1 avenue Poulhes, 31059, Toulouse, France
    Clin Rheumatol 25:566-7. 2006
    ..We described the second case of RS3PE following intravesical BCG instillation of bladder carcinoma...
  17. ncbi Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval
    Emmanuel Maheu
    Service de Rhumatologie, Hopital Saint Antoine, Paris, France
    Arthritis Res Ther 7:R1375-85. 2005
    ..6 or greater for assessing JSN over three years. Selecting a single reader was the most accurate method, with 0.3 mm precision. Using this cutoff, 50% of patients were classified as 'progressors'...
  18. ncbi The therapeutic approach to osteoarthritis
    Bernard Mazieres
    Department of Rheumatology, University Hospital of Rangueil, Toulouse, France
    Aging Clin Exp Res 15:405-12. 2003
    ..In other words, the treatment of OA requires an overall approach, associating pharmacological and non-pharmacological modalities...
  19. ncbi Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study
    Arnaud Constantin
    Department of Rheumatology and Immunology, CHU Rangueil, France
    J Rheumatol 29:15-20. 2002
    ..We investigated the association between a biallelic polymorphism in the MMP-1 gene promoter and the susceptibility to, and severity of, RA. We also investigated the association between HLA-DRB1 gene polymorphism and severity of RA...
  20. ncbi Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology
    Daniel Wendling
    Department of Rheumatology, CHU de Besancon, and EA 4266, Universite de Franche Comte, Besançon Paris Descartes University, Paris, France
    J Rheumatol 39:2327-31. 2012
    ..To evaluate the efficacy and safety of rituximab (RTX) in several subsets of spondyloarthritis (SpA) using the data of the AIR (Autoimmunity and Rituximab) registry...